As of 2024-12-12, the Intrinsic Value of Organogenesis Holdings Inc (ORGO) is
2.67 USD. This ORGO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 3.66 USD, the upside of Organogenesis Holdings Inc is
-27.00%.
The range of the Intrinsic Value is 1.86 - 5.52 USD
ORGO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
1.86 - 5.52 |
2.67 |
-27.0% |
| DCF (Growth 10y) |
3.41 - 10.96 |
5.08 |
38.9% |
| DCF (EBITDA 5y) |
6.48 - 8.60 |
7.31 |
99.7% |
| DCF (EBITDA 10y) |
9.07 - 13.64 |
10.89 |
197.4% |
| Fair Value |
-1.39 - -1.39 |
-1.39 |
-138.02% |
| P/E |
(0.99) - 2.62 |
0.57 |
-84.5% |
| EV/EBITDA |
3.91 - 8.43 |
5.32 |
45.5% |
| EPV |
1.39 - 1.91 |
1.65 |
-54.9% |
| DDM - Stable |
(0.51) - (2.30) |
(1.40) |
-138.3% |
| DDM - Multi |
2.15 - 7.74 |
3.39 |
-7.5% |
ORGO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
485.24 |
| Beta |
1.02 |
| Outstanding shares (mil) |
132.58 |
| Enterprise Value (mil) |
455.19 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.93% |
| Cost of Debt |
8.01% |
| WACC |
8.56% |